Danica Katz

Danica Katz has a diverse work experience spanning over two decades in the pharmaceutical industry. Danica currently serves as the Vice President of Global Clinical Operations at Secura Bio, Inc. since March 2022. Prior to this role, they held the position of Executive Director and Head of Clinical Trial Operations at the same company from July 2020 to March 2022.

Before joining Secura Bio, Inc., Danica worked at Amgen for a significant portion of their career. Danica held various roles at Amgen, including Director from September 2008 to July 2020. Danica also served as the Director of R&D Healthcare Compliance from October 2006 to September 2008. From September 2004 to October 2006, they were the Senior Clinical Manager in the Medical Affairs division, responsible for clinical trial operations and vendor relationships. Danica started their career at Amgen as a Sr/Clinical Research Associate from December 1998 to March 2002 and later became a Clinical Manager from March 2002 to September 2004.

Danica's early career began at Quintiles, where they worked as a Clinical Research Associate in Clinical Operations from June 1996 to December 1998.

Overall, Danica Katz has held various leadership and operational roles in the clinical research field, showcasing their expertise and experience in managing clinical operations at both domestic and global levels.

Danica Katz has a BA degree from UC San Diego and MA degrees from Miami University and Providence College.